Study of arrhythmia prevalence in NUVANT Mobile Cardiac Telemetry system patients

Abstract

The Corventis NUVANT™ Mobile Cardiac Telemetry system is an innovative solution in the field of continuous monitoring of symptomatic and asymptomatic cardiac abnormalities to help physicians diagnose and treat non-lethal cardiac arrhythmias. As an FDA cleared product on the market for more than 2 years, the collected body of patient data represents a unique and powerful source of clinical information. Analysis of a sample of 951 NUVANT patients has revealed interesting statistics on the prevalence of various cardiac arrhythmias in the patient population. The population is non-randomized and largely consists of US patients where a traditional Holter Monitor study was negative. The analysis here is focused on classifying the detected arrhythmias using potential therapy solutions as a classifier. Across the total population, 2.2% of patients presented arrhythmias indicating assessment for clinically significant tachycardia, 19% indications of potential bradycardia, 20% had indications of atrial fibrillation, 1% indicating arrhythmias requiring other conditional treatment, and 58% presenting arrhythmias likely not requiring treatment.

Novel Wireless Devices for Cardiac Monitoring

“…3 second pause, ventricular tachycardia). 7 There is also a patient trigger magnet that can be used to collect and transmit symptomatic episodes. All events are transmitted to a cloud-based application where it can be analyzed by certified electrocardiographic technicians.…”

A Novel Point-of-Care Smartphone Based System for Monitoring the Cardiac and Respiratory Systems

“…The fact that it offers only one lead may explain its significantly lower sensitivity compared to the conventional Holter monitor. The NUVANT, a wireless arrhythmia event monitor36 consists of a wearable (patch) monitoring device and a portable data transmission device. Unlike the Zio Patch, which records and stores all ECG data for retrospective arrhythmia detection, the NUVANT performs real-time analysis and transmission36.…”

Novel devices to monitor heart failure and minimize hospitalizations

“…A self-adhesive ECG patch monitor can be used to record a single lead ECG for up to 14 days and transmit data to a secure server; examples of such technology are Zio ® Patch [27] and NUNANT ® Mobile Cardiac Telemetry [28].…”